News
News

COBRE CAB meeting Fall 2023
September 19, 2023

COBRE Spurs New Research on Parkinson's Disease, Alzheimer's Disease
September 27, 2017

UNLV, Ruvo center get $11M to research Alzheimer’s, Parkinson’s.
September 4, 2015

Cleveland Clinic Lou Ruvo Center for Brain Health Teams With UNLV to Obtain $11.1 Million COBRE Grant
September 4, 2015
Past Events

Fall 2025 Community Advisory Board Meeting
December 17, 2025

COBRE Patient Appreciation Event
December 12, 2025

Center of Biomedical Research Excellence (COBRE Phase II)
April 11, 2024

Diversity Advisory Board Meeting
October 12, 2018

NISBRE 2018 meeting
July 18, 2018
The NISBRE is a national scientific meeting to showcase the scientific and training accomplishments of the IDeA program of the National Institute of General Medical Sciences (NIGMS). The IDeA program develops scientific centers of excellence and trains biomedical scientists in the IDeA eligible states

9th annual Sierra Nevada Chapter of the Society for Neuroscience & 2nd Annual Nevada COBRE Conference.
October 26, 2017
Speakers include Keynotes Jeffrey Cummings, Lou Ruvo Center for Brain Health, Las Vegas “Alzheimer’s Disease Drug Development: An Insider’s Perspective” and Marlene Behrmann, Psychology, Carnegie Mellon University “A Broader Vision of Object Recognition: Beyond Ventral Cortex”, plus 7 additional presentations throughout the day, including our own Project 3 leader, Dr. Jefferson Kinney.

2017 NIH IDEA Western Regional Conference
October 18, 2017
Wyoming INBRE welcomed faculty, administrators, staff and students from the NIH IDeA Western Region (Alaska, Hawaii, Idaho, Montana, Nevada, New Mexico, and Wyoming) and NIH administrators and staff to the fifth biennial NIH IDeA Western Regional Conference. The conference featured oral and poster scientific sessions, keynote talks, professional development workshops, and information sharing sessions with NIH officials.

Neuroscience NIPM Seminar
August 18, 2017
The Nevada Institute of Personalized Medicine (NIPM) seminar series integrated with the Lou Ruvo Center of Brain Health during the months of February – August of 2017.

NIGMS visit
May 17, 2017

1st Annual NV COBRE Conference
October 7, 2016
External News
Study Shows Possible Brain Recovery Among Fighters
SEPTEMBER 26, 2022
CLEVELAND – A study from Cleveland Clinic shows boxers and mixed martial arts fighters may see some recovery in their thinking and memory skills, as well as brain structure after they stop fighting. “What we found was that the folks who continued to fight, we saw slight declines in certain parts of the brain that…
Read MoreSurvey Shows Lack of Brain Health Awareness Among Women PKG
JUNE 28, 2022
CLEVELAND – Nearly two-thirds of Americans with Alzheimer’s disease are women, but according to a new Women’s Alzheimer’s Movement at Cleveland Clinic survey, 82% of women aren’t even aware that they’re at greater risk for developing the disease. “I was surprised by how many women didn’t know they were at risk for Alzheimer’s disease to …
Read MorePrevention Tips for Tick Bites and Lyme Disease
MAY 11, 2022
CLEVELAND – Warmer weather means people are ready to get outside, but it’s also time for ticks. Cleveland Clinic’s Dan Sullivan, MD, reminds us that these critters can transmit Lyme disease. “The early symptoms are the ones where you may have the neck stiffness, the muscle aches, a low-grade fever, the change in appetite, that …
Read MoreWomen’s Alzheimer’s Movement at Cleveland Clinic Announces Its Latest Research Grant Recipients
JUNE 1, 2022
In recognition of June as Alzheimer’s and Brain Awareness Month, the Women’s Alzheimer’s Movement at Cleveland Clinic (WAM at Cleveland Clinic) today announced the recipients of the 2021 WAM research grants, seed funding for innovative women-based Alzheimer’s disease research studies, which will be conducted over two years, 2022-2023. The five funded projects are aimed at …
Read MoreWorking together for women’s brain health
MAY 3, 2022
In a Las Vegas Review-Journal op-ed, Jessica Caldwell, Ph.D., director of The Women’s Alzheimer’s Movement Prevention Center at Cleveland Clinic, called for innovative clinical care, science, education and funding to address Alzheimer’s disease in women. Of the 6.5 million Americans currently diagnosed with Alzheimer’s disease, almost two-thirds are women. In addition, more than half of …
Read MoreDo Word Games Help with Brain Health?
APRIL 22, 2022
CLEVELAND – It seems like word games have grown in popularity over the years. They’re a fun and easy way to stay entertained. But, did you know they can also help keep your brain healthy? “My idea about those types of word games is if you enjoy them and they’re giving you a challenge, so …
Read MoreOne Drink a Day Could Shrink your Brain, Study Finds
APRIL 11, 2022
CLEVELAND – A new study shows that even having just one beer or glass of wine per day can shrink your brain, and it gets worse the more you drink. So, how can that impact a person’s brain health? “This study that looked at alcohol and brain volume didn’t look at cognition or day-to-day life …
Read MoreBrain Issues Commonly Seen in Women
MARCH 14, 2022
CLEVELAND – March 14-20 is Brain Awareness week, which is a good time to remind women about neurological issues they need to look out for and when to seek care. ‘ “Women face a lot of common brain issues, but particularly as we age, we go through some things that can really look like a …
Read MoreNIH Awards $11.3 Million Grant to Continue Funding Center for Neurodegeneration and Translational Neuroscience in Southern Nevada
FEBRUARY 17, 2022
Collaboration between Cleveland Clinic Lou Ruvo Center for Brain Health and University of Nevada, Las Vegas, to enhance neuroscience research infrastructure in southern Nevada
Read MoreThe Women’s Alzheimer’s Movement Prevention Center at Cleveland Clinic Marks First Anniversary with NIH Grant to Study Effects of Gender and Sex in Alzheimer’s Disease
SEPTEMBER 8, 2021
Las Vegas: Jessica Caldwell, Ph.D., director of The Women’s Alzheimer’s Movement Prevention Center at Cleveland Clinic, has been awarded a grant expected to total $1.8 million from the National Institute on Aging at the National Institutes of Health (NIH) to study the interactive effects of gender and sex on biological processes in Alzheimer’s disease. The four-year grant will examine how gender-linked stress exposure …
Read MoreUFC Extends Commitment to Cleveland Clinic’s Professional Athletes Brain Health Study
JANUARY 7, 2021
Las Vegas – UFC®, the world’s premier mixed martial arts organization, today announced a five-year extension of its longstanding collaboration with Cleveland Clinic, and its continued support of the Professional Athletes Brain Health Study. This multi-year commitment, which is supported by a $1 million contribution to the Lou Ruvo Center for Brain Health in Las …
Read MoreWhy Working Women May Have Better Memory as they Age
NOVEMBER 27, 2020
CLEVELAND – As we close out November and Alzheimer’s Awareness Month, a recent study shows women who work tend to have better memory later in life. “I think it’s surprising because we know that things like education can boost our thinking as we age, or cognitive activity can boost our thinking as we age. But …
Read MoreNational Institute of Neurological Disorders and Stroke Awards $3.8 Million to Cleveland Clinic Researcher to Predict Dementia in Parkinson’s Disease Patients
OCTOBER 6, 2020
Las Vegas: The National Institute of Neurological Disorders and Stroke at the National Institutes of Health (NIH) has awarded a grant expected to total $3.8 million to Virendra Mishra, Ph.D., associate staff at Cleveland Clinic Lou Ruvo Center for Brain Health , to identify biomarkers – or disease indicators – to predict dementia in patients with Parkinson’s disease.
Read MoreThe Women’s Alzheimer’s Movement Prevention Center at Cleveland Clinic Launches
JUNE 18, 2020
Las Vegas: As part of Alzheimer’s and Brain Awareness Month, Cleveland Clinic and The Women’s Alzheimer’s Movement (WAM) today opened The Women’s Alzheimer’s Movement Prevention Center at Cleveland Clinic (The Women’s Alzheimer’s Prevention Center) – the first Alzheimer’s prevention clinic designed just for women. Building on peer-reviewed science indicating that up to one-third of all …
Read MoreHow Can Women Reduce Alzheimer’s Risk?
JUNE 17, 2020
June is Alzheimer’s and Brain Awareness Month. About two-thirds of people with Alzheimer’s disease are women. According to Jessica Caldwell, PhD, of Cleveland Clinic Lou Ruvo Center for Brain Health, we can’t change every risk factor that plays into developing Alzheimer’s – but there are some ways women can reduce their risk. “Some of the …
Read MoreCleveland Clinic Releases Fourth Installment of Annual Alzheimer’s Disease Drug Development Pipeline Report
JULY 10, 2019
Cleveland Clinic’s fourth annual analysis of Alzheimer’s disease drug development found that the pipeline has grown in the number and variety of agents being tested over the past year, while highlighting several advances in the field including new clinical trial designs, more detailed criteria for making a research diagnosis, and an increased use of biological …
Read MoreCleveland Clinic Lou Ruvo Center for Brain Health Obtains Sole Investigational New Drug License for GE180 Tracer to Detect Neuroinflammation in the Brains of Those with Parkinson’s and Alzheimer’s Disease
JANUARY 16, 2019
Las Vegas: The Cleveland Clinic Lou Ruvo Center for Brain Health has obtained the only Investigational New Drug (IND) to be issued by the Federal Drug Administration to test the GE180 ligand tracer, an experimental diagnostic imaging tool used to detect neuroinflammation, in the brains of those with Parkinson’s and Alzheimer’s disease. Ligand tracers are …
Read MoreCleveland Clinic Analysis Finds that Drug Development in Alzheimer’s Still Inadequate
AUGUST 9, 2018
Cleveland Clinic’s third annual analysis of Alzheimer’s disease drug development reveals that drug development continues to be disappointingly slow. Researchers, however, are learning more about evolving targets in the pipeline, including a movement toward disease prevention and an emphasis in disease-modifying therapies. The paper, Alzheimer’s disease drug development: pipeline 2018, is based on the federal …
Read MoreDevelopment of New Alzheimer’s Drugs Lagging, Cleveland Clinic Report Finds
JUNE 22, 2017
LAS VEGAS: Cleveland Clinic’s annual analysis of Alzheimer’s disease drug development highlights an urgent need to increase the number of drugs entering the pipeline and to accelerate the drug testing and approval process. Without changes, the likelihood of reaching the national goal to develop a meaningful therapy by 2025, as established by the Obama …
Read More
